NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
about
Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKLMicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for OsteoporosisOsteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone LossOsteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activityNegative autoregulation of RANKL and c-Src signaling in osteoclastsForkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expressionPlacotylene A, an inhibitor of the receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation, from a Korean sponge Placospongia sp.Embryonic Development of the Bicuspid Aortic Valve.Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesisBaicalin positively regulates osteoclast function by activating MAPK/Mitf signalling.Cloning and characterization of osteoclast precursors from the RAW264.7 cell lineTranscriptional regulation of bone and joint remodeling by NFATNIP45 negatively regulates RANK ligand induced osteoclast differentiation.TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages.Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cellsReceptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.Proapoptotic function of integrin beta(3) in human hepatocellular carcinoma cells.The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).NADPH oxidase gp91(phox) contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1Transgenic mice with OIP-1/hSca overexpression targeted to the osteoclast lineage develop an osteopetrosis bone phenotype.RCANs regulate the convergent roles of NFATc1 in bone homeostasis.Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts.Targeting integrins to promote bone formation and repair.Regulatory mechanisms of RANKL presentation to osteoclast precursors.Repositioning Potential of PAK4 to Osteoclastic Bone Resorption.The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes.Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway.Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis.Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in rats.Decreased SH3BP2 inhibits osteoclast differentiation and functionMyocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.Impaired micro-RNA pathways diminish osteoclast differentiation and function.The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice via Suppression of Osteoclast Formation and Bone Resorption.Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.Decoy receptor 3 suppresses RANKL-induced osteoclastogenesis via down-regulating NFATc1 and enhancing cell apoptosis.Clinically Relevant Concentrations of Ketamine Inhibit Osteoclast Formation In Vitro in Mouse Bone Marrow Cultures.Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.
P2860
Q24632345-E15ED4F6-53D4-49A6-AFB9-7DC3E21A8608Q26752588-E0707784-CC2A-4F44-9401-62DA2ECA67C5Q27008993-AF319D60-9A03-47A5-A7EE-9B9700F3E4A2Q28274725-F45013E0-FA36-4361-9642-E65EDFB17CB4Q28307600-04C4F499-DE46-408B-B811-14761420BC13Q28587296-5AB13561-CFE3-4316-A368-453214754B67Q33575706-0F6E1089-CE9A-49BC-9169-57ACD7DAD66DQ33708015-9E654EC5-5732-4A8F-9C8F-13BFA3913C73Q33736852-78A287CA-8FF9-48D1-915E-FA53409A390DQ33844646-EE401295-3D7C-4CEE-9315-0A74EBDB2091Q33906787-733D9DEB-9EC0-4F5E-9B1B-A5D79422B8D9Q33998768-E8913BD1-F8FB-488B-9101-835116394279Q34128188-FB806F7C-841D-450F-8DA2-90CB4F117FFDQ34533668-58BECA38-83A0-4033-B20F-99FF3B0AD5DEQ34968667-56736E17-B465-4B10-9EE0-7831AB6F0A03Q36487636-D4C07562-7A66-4478-9809-3ACDC3064B73Q36857816-E655A052-0A2E-45B9-B745-05A216B7DD5CQ36907683-03DD161C-9DD0-4C59-8970-474B9D0D318FQ37143375-8FA798FE-E8CE-4FBA-A72C-AF4EA9CB1FA4Q37302319-C16E2931-71C9-47B9-8532-97898F6BAEFFQ37448881-F5121828-7D27-4C7E-B65F-71EE5DA4F464Q37453357-B64645FD-396B-44CC-BB87-4EF17EE5F9FBQ37472044-6E6363E1-FB3C-42F7-A572-12C3BF09F33EQ37829690-B5B564E8-D291-4F23-9718-165F363EB68CQ38074961-9D7C9561-D6FA-4D0B-ACC9-8F2A2C244329Q38077443-14E5FE31-97D9-477E-9D25-55415D0ECBA5Q38183261-2D35ECEE-3D06-4FA0-AD8E-341248463F06Q38428915-1EC6459D-5451-452B-9410-170C38152CEAQ38669228-52DB7F74-26FC-4A2B-8CFF-176F19D754DCQ39085200-27EE2C24-A23D-4A48-983E-A6C22D2903DEQ39139785-4EBA518D-2E5A-4793-BCB2-2FBA847B450CQ39264023-8502B0FF-B66D-447B-A0CB-2B6FD8F1200CQ39568444-D26E3840-CC3E-4200-B603-F5716535A2A8Q39868307-C759F368-CB3A-45EF-827C-A1E4AA55157DQ39908266-009A9EA1-542D-47AE-A9EE-BD4381F20C70Q41684447-03415BD1-503D-4B1C-82FF-F4D4502F61F2Q42270419-981E457D-4AA6-47E3-9419-EFEFA4F55ADFQ44496075-6B96077B-01F2-4D95-94D1-2CB6F23589F0Q47373904-D8470F01-D872-4097-B8DB-0BEBEDA5E508Q47944184-9B70613D-32B5-4184-ABF5-F99770788DA0
P2860
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@ast
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@en
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@nl
type
label
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@ast
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@en
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@nl
prefLabel
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@ast
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@en
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@nl
P2093
P2860
P1433
P1476
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
@en
P2093
Joseph D Fleming
Kevin P McHugh
Merrilee Flannery
Nicole C Walsh
Steven R Goldring
Tania N Crotti
P2860
P304
P356
10.1016/J.GENE.2005.12.012
P407
P577
2006-03-02T00:00:00Z